Bioprocess R&D: Beginning With The End In Mind

In a period marked by resource constraints, focusing R&D on the most likely molecules to succeed is paramount. But, how do you do it? On this Bioprocess Online Live event, we explored the most efficient approaches to scalable discovery, molecular screening and assays, definition of CQAs, establishing a proof of concept, and assessing developability. Bioprocess Online’s Matt Pillar as joined by Amgen VP of Research Dr. Robert Stoffel, and Cullinan Oncology President & CEO Nadim Ahmed. Available on-demand.